Insulin glulisine
Apidra (insulin glulisine) is a protein pharmaceutical. Insulin glulisine was first approved as Apidra on 2004-04-16. It has been approved in Europe to treat diabetes mellitus.
| Trade Name | Apidra |
|---|---|
| Common Name | Insulin glulisine |
| Indication | diabetes mellitus |
| Drug Class |
